SCHEMBL7870040

SCHEMBL7870040

[CH](CCc1ccncc1)c1ccco1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.39
POLB P06746 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 3/20 0.38
LOXL2 Q9Y4K0 1/20 0.38
GPR52 Q9Y2T5 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
LMNA P02545 2/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 3/20 0.35
MEN1 O00255 1/20 0.35
APOBEC3A P31941 1/20 0.35
HTT P42858 1/20 0.35
BLM P54132 1/20 0.35
KMT2A Q03164 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CYP3A4 P08684 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6569729 0.84 GPR52 (0.50) CYP1A2POLBKDM4EALDH1A1GPR52
SCHEMBL11516112 0.74 POLB (0.42) CYP1A2POLBKDM4EALDH1A1NPC1
SCHEMBL5471638 0.74 ALDH1A1 (0.49) POLBKDM4EALDH1A1LMNAMAPT
SCHEMBL8091560 0.74 ALDH1A1 (0.46) CYP1A2POLBKDM4EALDH1A1GPR52
SCHEMBL5805649 0.73 ALDH1A1 (0.49) CYP1A2POLBKDM4EALDH1A1NPC1
SCHEMBL1255865 0.71 LOXL2 (0.43) CYP1A2KDM4EALDH1A1LOXL2NPC1
SCHEMBL270347 0.70
SCHEMBL1383658 0.68 G6PC1 (0.50) POLBKDM4EALDH1A1NPC1RAB9A
SCHEMBL27411167 0.68 LOXL2 (0.54) CYP1A2ALDH1A1LOXL2GPR52MEN1
SCHEMBL7471622 0.68 ALDH1A1 (0.46) CYP1A2KDM4EALDH1A1LOXL2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6316496-B1 FOR THERAPY OF RETROVIRAL INFECTION; PROPHYLAXIS OF REPLICATION OF RETROVIRUS, THERAPY OF AIDS (ACQUIRED IMMUNE DEFICIENCY SYNDROME) G. D. SEARLE & CO. 2001-11-13 US disclosed